What Role Do Nanoparticles Play in Drug Delivery for IBD?
Traditional therapies for IBD often suffer from poor bioavailability and systemic side effects. Nanoparticle-based drug delivery systems offer a promising alternative by enhancing the targeted delivery of therapeutic agents to the inflamed regions of the gut. Liposomal formulations and polymeric nanoparticles can encapsulate anti-inflammatory drugs, protecting them from degradation in the gastrointestinal environment and releasing them selectively at the site of inflammation. This targeted approach reduces the required dosage and minimizes systemic side effects.
